European Commission approves expanded age indication for GSK’s Arexvy, the first …
GSK plc (LSE/NYSE: GSK) today announced that the European Commission has authorised Arexvy (respiratory syncytial virus vaccine, recombinant …Read More
The Heartbeat of World events
GSK plc (LSE/NYSE: GSK) today announced that the European Commission has authorised Arexvy (respiratory syncytial virus vaccine, recombinant …Read More